Cell Source, Inc. Other Noncash Income (Expense)
Cell Source, Inc. (CLCS) reported Other Noncash Income (Expense) of $135.92 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-04-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-04-07
- Cell Source, Inc. other noncash income (expense) for the quarter ending 2024-12-31 was $208.40K, a 20.21% increase year-over-year.
- Cell Source, Inc. other noncash income (expense) for the quarter ending 2024-09-30 was -$134.28K.
- Cell Source, Inc. other noncash income (expense) for the quarter ending 2024-06-30 was -$12.50K.
- Cell Source, Inc. other noncash income (expense) for the quarter ending 2024-03-31 was $74.31K, a 61.10% increase year-over-year.
- Cell Source, Inc. other noncash income (expense) for fiscal 2024 was $135.92K, a 6.04% decline from fiscal 2023.
- Cell Source, Inc. other noncash income (expense) for fiscal 2023 was $144.66K.
- Cell Source, Inc. other noncash income (expense) for fiscal 2022 was -$102.36K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|
| 2024-12-31 | $208.40K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $74.11K derived: sum of 2 quarters · filed 2026-04-07 | $61.61K derived: sum of 3 quarters · filed 2026-04-07 | $135.92K 10-K · filed 2026-04-07 |
| 2024-09-30 | -$134.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$146.79K derived: sum of 2 quarters · filed 2024-11-14 | -$72.47K 10-Q · filed 2024-11-14 | $100.88K derived: sum of 4 quarters · filed 2026-04-07 |
| 2024-06-30 | -$12.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $61.81K 10-Q · filed 2024-08-19 | $235.17K derived: sum of 3 quarters · filed 2026-04-07 | $187.61K derived: sum of 4 quarters · filed 2026-04-07 |
| 2024-03-31 | $74.31K 10-Q · filed 2024-07-29 | $247.67K derived: sum of 2 quarters · filed 2026-04-07 | $200.12K derived: sum of 3 quarters · filed 2026-04-07 | $172.84K derived: sum of 4 quarters · filed 2026-04-07 |
| 2023-12-31 | $173.36K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $125.80K derived: sum of 2 quarters · filed 2026-04-07 | $98.53K derived: sum of 3 quarters · filed 2026-04-07 | $144.66K 10-K · filed 2026-04-07 |
| 2023-09-30 | -$47.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$74.83K derived: sum of 2 quarters · filed 2024-11-14 | -$28.70K 10-Q · filed 2024-11-14 | -$34.15K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$27.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $18.86K 10-Q · filed 2024-08-19 | $13.40K derived: sum of 3 quarters · filed 2024-08-19 | |
| 2023-03-31 | $46.13K 10-Q · filed 2024-07-29 | $40.67K derived: sum of 2 quarters · filed 2024-07-29 | ||
| 2022-12-31 | -$5.46K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-24 | -$102.36K 10-K · filed 2024-06-24 | ||
| 2022-09-30 | -$96.90K 10-Q · filed 2023-11-09 |